Associated Papers
Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study.
De Greef J et al.
The Journal of Infectious Diseases, 2025
40036182 (PubMed )
Supplement: jiaf098_supplementary_data.zip › Dolutegravir_and_Risk_of_NPAE_Suppl_final_REVISED_clean.docx
ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
Bruckmueller H et al.
Expert Opinion on Drug Metabolism & Toxicology, 2021
Effects of Polymorphisms in NR1H4, NR1I2, SLCO1B1, and ABCG2 on the Pharmacokinetics of Rosuvastatin in Healthy Chinese Volunteers.
Liu M et al.
Journal of Cardiovascular Pharmacology, 2016
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.
Cascorbi I
Pharmacology & Therapeutics, 2006
Select a paper to view details